BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
11.70
-0.12 (-1.02%)
Sep 26, 2025, 4:00 PM EDT - Market closed
BBOT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Selling, General & Admin | 9.27 | 7.76 | 8.49 |
| Research & Development | 85.5 | 73.11 | 56.29 |
| Operating Expenses | 94.77 | 80.86 | 64.77 |
| Operating Income | -94.77 | -80.86 | -64.77 |
| Interest & Investment Income | 8.08 | 6.38 | 0.07 |
| Other Non Operating Income (Expenses) | -0.81 | 0.21 | - |
| Pretax Income | -87.5 | -74.28 | -64.7 |
| Net Income | -87.5 | -74.28 | -64.7 |
| Net Income to Common | -87.5 | -74.28 | -64.7 |
| Shares Outstanding (Basic) | 0 | 0 | 0 |
| Shares Outstanding (Diluted) | 0 | 0 | 0 |
| Shares Change (YoY) | - | 16.36% | - |
| EPS (Basic) | -268.56 | -511.80 | -518.73 |
| EPS (Diluted) | -268.56 | -511.80 | -518.73 |
| Free Cash Flow | -81.31 | -55.08 | -52.49 |
| Free Cash Flow Per Share | -249.57 | -379.51 | -420.87 |
| EBITDA | -94.55 | -80.66 | -64.68 |
| D&A For EBITDA | 0.23 | 0.21 | 0.09 |
| EBIT | -94.77 | -80.86 | -64.77 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.